These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16806858)

  • 1. Review of global regulations concerning biowaivers for immediate release solid oral dosage forms.
    Gupta E; Barends DM; Yamashita E; Lentz KA; Harmsze AM; Shah VP; Dressman JB; Lipper RA
    Eur J Pharm Sci; 2006 Nov; 29(3-4):315-24. PubMed ID: 16806858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report.
    Skelly JP; Van Buskirk GA; Savello DR; Amidon GL; Arbit HM; Dighe S; Fawzi MB; Gonzalez MA; Malick AW; Malinowski H
    J Parenter Sci Technol; 1993; 47(2):52-6. PubMed ID: 8515344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical Considerations Concerning Dissimilar Regulatory Requirements for Dissolution Similarity Assessment. The Example of Immediate-Release Dosage Forms.
    Jasińska-Stroschein M; Kurczewska U; Orszulak-Michalak D
    J Pharm Sci; 2017 May; 106(5):1275-1284. PubMed ID: 28088455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N; Löbenberg R
    Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaleup of immediate release oral solid dosage forms.
    Skelly JP; Van Buskirk GA; Savello DR; Amidon GL; Arbit HM; Dighe S; Fawzi MB; Gonzalez MA; Malick AW; Malinowski H
    Pharm Res; 1993 Feb; 10(2):313-6. PubMed ID: 8456084
    [No Abstract]   [Full Text] [Related]  

  • 12. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.
    Crane C; Santos GML; Fernandes EAF; Simon C; Tam A; Triana DG; Potthast H; Kuribayashi R; Okada Y; Myoenzono A; Calderon IO; Rodriguez Z; Jones B; Park SA; Eum SY; Rodrigues C; Van Oudsthoorn J; Nolting A; Walther C; Roost MS; Hung WY; Braddy AC; Garcia-Arieta A
    J Pharm Pharm Sci; 2019; 22(1):486-500. PubMed ID: 33760728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement on fixed ratio combinations of drugs.
    Moss JM
    Va Med Mon (1918); 1971 Sep; 98(9):472-3. PubMed ID: 5119159
    [No Abstract]   [Full Text] [Related]  

  • 15. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the dissolution test in controlling the bioavailability of solid oral pharmaceutical forms].
    Carli F; Ceriani D; Frattini C; Gorlato P; Maffione G; Moro L; Neri G; Ciranni Signoretti E
    Ann Ist Super Sanita; 1982; 18(3):551-8. PubMed ID: 7187844
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms.
    Tang B; Cheng G; Gu JC; Xu CH
    Drug Discov Today; 2008 Jul; 13(13-14):606-12. PubMed ID: 18598917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterfeits kill!
    Ghebrehiwet T
    Imprint; 2006; 53(3):40-4. PubMed ID: 16821529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. C. Automated methods.
    Horwitz W; Albert R
    J Assoc Off Anal Chem; 1985; 68(1):112-21. PubMed ID: 3980400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.